clear space clear space clear space white space
A
 r c h i v e s   o f   M a r y l a n d   O n l i n e

PLEASE NOTE: The searchable text below was computer generated and may contain typographical errors. Numerical typos are particularly troubling. Click “View pdf” to see the original document.

  Maryland State Archives | Index | Help | Search
search for:
clear space
white space
Session Laws, 2005
Volume 752, Page 1969   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>
clear space clear space clear space white space
ROBERT L. EHRLICH, JR., Governor                             Ch. 425 (ii) Distribute medication to enrollees who have been approved to
participate in a manufacturer's patient assistance program.
(f) (1) The Medbank of Maryland, Inc. shall ensure that the Program is
available to residents in each of the following geographic regions of the State:
(i) Western Maryland; (ii) The Eastern Shore; (iii) The Baltimore metropolitan area; (iv) The Maryland counties in the Washington, D.C. metropolitan
area; and
(v) Southern Maryland, including Anne Arundel County. (2) Medbank of Maryland, Inc. shall be the central coordinating office for
the State.
(g) Eligibility for the Program shall be limited only by the criteria established
by pharmaceutical manufacturers for their patient assistance programs.
(h) (1) The Department shall require detailed financial reports at least
quarterly from Medbank of Maryland, Inc.
(2) The Medbank of Maryland, Inc. shall release funds to the entities
that operate the Program as needed and justified by the quarterly reports filed in
accordance with paragraph (1) of this subsection.
(i) On or before December 1, 2001, and annually thereafter, the Department
and Medbank of Maryland, Inc. shall report to the Governor and, in accordance with
§ 2-1246 of the State Government Article, to the General Assembly, on the status of
the Maryland Medbank Program established under this section, including:
(1) The number and demographic characteristics of the State residents
served by the Program;
(2) The types and retail value of prescription drugs accessed through the
Program;
(3)     The nature and extent of outreach performed to inform State
residents of the assistance available through the Program; and
(4)     The total volume and retail value of each brand name drug, by
manufacturer, accessed through the Program.
ArticleInsurance 14-102. (h) The provisions of subsections (d) and (e) of this section and §§ [14-106,
14-115(d), (c), (f), and (g)] 14-106, 14-10
6.1, 14-115(D), (E), (F), AND (G), and 14-139(d)
- 1969 -


 
clear space
clear space
white space

Please view image to verify text. To report an error, please contact us.
Session Laws, 2005
Volume 752, Page 1969   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>


This web site is presented for reference purposes under the doctrine of fair use. When this material is used, in whole or in part, proper citation and credit must be attributed to the Maryland State Archives. PLEASE NOTE: The site may contain material from other sources which may be under copyright. Rights assessment, and full originating source citation, is the responsibility of the user.


Tell Us What You Think About the Maryland State Archives Website!



An Archives of Maryland electronic publication.
For information contact mdlegal@mdarchives.state.md.us.

©Copyright  August 17, 2024
Maryland State Archives